Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-17T19:39:56.499Z Has data issue: false hasContentIssue false
  • English
  • Français

10-03 Identifying pathways to depressed mood and cognitive dysfunction: the BDNF Val66Met polymorphism and early life stress

Published online by Cambridge University Press:  24 June 2014

JM Gatt ,
S Kuan ,
C Dobson-Stone ,
RH Paul ,
PR Schofield ,
E Gordon  and
LM Williams
JM Gatt
Affiliation:
The Brain Dynamics Centre, Westmead Millennium Institute, Westmead Hospital and Western Clinical School, University of Sydney, Australia
S Kuan
Affiliation:
The Brain Dynamics Centre, Westmead Millennium Institute, Westmead Hospital and Western Clinical School, University of Sydney, Australia
C Dobson-Stone
Affiliation:
Prince of Wales Medical Research and Garvan Institutes, Australia
RH Paul
Affiliation:
Brown Medical School, USA
PR Schofield
Affiliation:
Prince of Wales Medical Research and Garvan Institutes, Australia
E Gordon
Affiliation:
The Brain Resource International Database (The Brain Resource Company), Australia
LM Williams
Affiliation:
The Brain Dynamics Centre, Westmead Millennium Institute, Westmead Hospital and Western Clinical School, University of Sydney, Australia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstracts from ‘Brainwaves’— The Australasian Society for Psychiatric Research Annual Meeting 2006, 6–8 December, Sydney, Australia
Information
Acta Neuropsychiatrica , Volume 18 , Issue 6 , December 2006 , pp. 336 - 337
Copyright
Copyright © 2006 Blackwell Munksgaard

Background:

The BDNF Val66Met polymorphism involves a valine (Val) to methionine (Met) substitution, with the Met allele implicated in phenotypes (poor memory, depressed mood) and endophenotypes (abnormal hippocampal-prefrontal function) of depression. Given a well-established link between stress and depression, we examined whether early life stress moderates the depressogenic and related cognitive effects of BDNF Val66Met in humans and whether hippocampal loss and autonomic dysregulation mediate these effects.

Methods:

About 374 healthy subjects from the Brain Resource International Database provided data from cheek swabs (for genotyping), cognitive tests, psychometric questionnaires of mood and personality, tonic and phasic measures of autonomic function (average heart rate and variability during resting conditions and during cognitive- and emotion-related tasks) and magnetic resonance imaging.

Results:

Path analysis showed that with increasing stress, BDNF Met status predicts direct effects on hippocampal loss and indirect effects on depressed mood and poor cognition (working memory, executive function/processing speed, verbal memory). These effects were mediated by gray matter atrophy, autonomic dys-regulation (raised average heart rate, reduced heart rate variability) and neuroticism.

Conclusions:

The findings suggest that the BDNF Met allele carriers may show an increased risk for structural brain deficits and autonomic dysregulation if exposed to at least three or more stressful early life events. Alterations of this nature may consequently predispose such individuals to emotional and cognitive dysfunctions. These findings may have implications for understanding the pathways to psychiatric disorders of cognition and mood, and may provide some guide to the tailoring of treatment according to the patient's genetic/endophenotypic profile.